Cargando…

Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System

Background: Information on patient’s death is a major outcome of health-related research, but it is not always available in claim-based databases. Herein, we suggested the operational definition of death as an optimal indicator of real death and aim to examine its validity and application in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Suk-Chan, Kwon, Sun-Hong, Min, Serim, Jo, Ae-Ryeo, Lee, Eui-Kyung, Nam, Jin Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243505/ https://www.ncbi.nlm.nih.gov/pubmed/35784684 http://dx.doi.org/10.3389/fphar.2022.906211

Ejemplares similares

Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data
por: Kwon, Sun-Hong, et al.
Publicado: (2022)

Health-related quality of life in adult patients with asthma according to asthma control and severity: A systematic review and meta-analysis
por: Oh, Byeong-Chan, et al.
Publicado: (2022)

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
por: Jang, Ha Young, et al.
Publicado: (2022)

Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements
por: Oh, Byeong-Chan, et al.
Publicado: (2023)

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
por: Zhang, Qiongwen, et al.
Publicado: (2023)

Pharmacoepidemiology Research-Real-World Evidence for Decision Making
por: Bérard, Anick
Publicado: (2021)

Editorial: Real-world experience with CFTR modulator therapy
por: Tümmler, Burkhard, et al.
Publicado: (2023)

ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts
por: Li, Zhiwei, et al.
Publicado: (2023)

Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology
por: Wei, James Cheng-Chung, et al.
Publicado: (2020)

Drug utilization research in Peru: Is real-world data available?
por: Rodríguez-Tanta, L. Yesenia, et al.
Publicado: (2023)

Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and Efficacy
por: Oi Yan Chan, Joyce, et al.
Publicado: (2022)

Real World Data in Health Technology Assessment of Complex Health Technologies
por: Hogervorst, Milou A., et al.
Publicado: (2022)

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
por: Yang, Hyun, et al.
Publicado: (2022)

Editorial: The use of real world data for regulatory purposes in the rare diseases setting
por: Giannuzzi, Viviana, et al.
Publicado: (2022)

A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
por: Ramos-Rincón, José Manuel, et al.
Publicado: (2023)

Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
por: Roberti, Roberta, et al.
Publicado: (2021)

Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands
por: van Laar, S.A., et al.
Publicado: (2022)

Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2021)

Real-world disparities and ethical considerations with access to CFTR modulator drugs: Mind the gap!
por: Zampoli, M., et al.
Publicado: (2023)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023)

Homoharringtonine Inhibits Allergic Inflammations by Regulating NF-κB-miR-183-5p-BTG1 Axis
por: Kim, Misun, et al.
Publicado: (2020)

A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments
por: Byun, Joo-Young, et al.
Publicado: (2021)

Real-World Patterns of Pharmacotherapeutic Management of Asthma Patients With Exacerbations in the Spanish National Health System
por: Hurtado, Isabel, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
por: Wang, Li, et al.
Publicado: (2021)

Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
por: Umetsu, Ryogo, et al.
Publicado: (2021)

Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
por: Zheng, Zhuangzhuang, et al.
Publicado: (2022)

Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis
por: de Castro, Caroline Tianeze, et al.
Publicado: (2022)

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges
por: Radtke, Kendra K., et al.
Publicado: (2023)

Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study
por: Lan, Yingxia, et al.
Publicado: (2023)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
por: Wu, Yan, et al.
Publicado: (2023)

Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
por: Li, Na, et al.
Publicado: (2023)

Approach to machine learning for extraction of real-world data variables from electronic health records
por: Adamson, Blythe, et al.
Publicado: (2023)

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs
por: Boyadzhieva, Vladimira, et al.
Publicado: (2018)

Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
por: Sultana, Janet, et al.
Publicado: (2020)

Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
por: Zhang, Jinhua, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine Use During Pregnancy and the Risk of Adverse Pregnancy Outcomes Using Real-World Evidence
por: Bérard, Anick, et al.
Publicado: (2021)

Pharmacological Treatment of Diabetic and Non-Diabetic Patients With Coronary Artery Disease in the Real World of General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2022)

Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data
por: Shao, Qi-hui, et al.
Publicado: (2021)

Effectiveness and Economic Evaluation of Polyene Phosphatidyl Choline in Patients With Liver Diseases Based on Real-World Research
por: Fan, Jian-Gao, et al.
Publicado: (2022)

Appropriateness of Antibiotic Prescribing in Hospitalized Children: A Focus on the Real-World Scenario of the Different Paediatric Subspecialties
por: Nasso, Chiara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ufi71v8uej0mj3kj2u0pkkhgu